文献速递生殖医学

卵巢刺激中重组HCG与重组LH生物等效剂量产生相似雌二醇输出:一项随机对照研究

Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled study.
PubMed 文献 · Reprod Biomed Online · 2017-05-11

这项随机对照研究在长方案促性腺激素释放激素激动剂降调节下,比较重组FSH联合每日微剂量重组HCG或重组LH(1:1生物活性比)从刺激第1天开始的效果。100例患者完成研究,主要终点扳机日雌二醇水平在HCG组中位数为8662 pmol/l,重组LH组为9203 pmol/l,无显著差异;获卵数和活产率亦无差异。

要点

  • 长方案降调节下,重组FSH联合微剂量重组HCG或重组LH(1:1生物活性比)从刺激第1天开始。
  • 扳机日雌二醇中位数:HCG组8662 pmol/l vs 重组LH组9203 pmol/l,无显著差异。
  • 获卵数和活产率两组间亦无差异。

核心结论

  • 当以1:1生物活性比使用时,重组HCG与重组LH在卵巢刺激期间增强雌二醇合成方面同等有效。

研究设计与样本

  • 随机对照研究,在长方案促性腺激素释放激素激动剂降调节下,比较重组FSH联合每日微剂量重组HCG或重组LH(1:1生物活性比)从刺激第1天开始。
  • 共100例来自公共诊所的患者完成研究。
  • 主要终点为扳机日雌二醇水平。

主要发现

  • 扳机日雌二醇中位数在HCG补充组为8662 pmol/l,在重组LH补充组为9203 pmol/l,无显著差异。
  • 获卵数无差异。
  • 活产率无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In nature, HCG is secreted by the implanting embryo from peri-implantation and onwards. In contrast, LH is mandatory for steroidogenesis and follicular development during the follicular phase, working in synergy with FSH. Moreover, LH is mandatory for the function of the corpus luteum. Although LH and HCG bind to the same receptor, significant molecular, structural and functional differences exist, inducing differences in bioactivity. This randomized controlled study compared the effect of recombinant FSH stimulation combined with daily either micro-dose recombinant HCG or recombinant LH supplementation in a 1:1 bioactivity ratio from day 1 of stimulation in a long gonadotrophin releasing hormone agonist down regulation protocol. A total of 100 patients from a public clinic completed the study. The primary end-point was the oestradiol level on the day of ovulation trigger and the median oestradiol level in the HCG supplemented group was 8662 pmol/l versus 9203 pmol/l in the recombinant LH supplemented group; therefore, no significant difference was found. Moreover, no differences were observed in the number of oocytes retrieved or in the live birth rate. We conclude that recombinant HCG and recombinant LH are equally effective in boosting oestradiol synthesis during ovarian stimulation when used in a 1:1 bioactivity ratio.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Alsbjerg B, Elbaek HO, Laursen RJ, et al. Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled study. Reprod Biomed Online. 2017. PMID: 28532660. doi:10.1016/j.rbmo.2017.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。